[ad_1]
RIO – Brazil this Friday surpassed the mark of 6 million infected by the new coronavirus. The country registered 34,516 new cases of Covid-19, reaching the level of 6,017,605 occurrences, according to a consortium of press vehicles. 521 deaths were also reported, which has meant a total of 168,662 since the arrival of the disease in Brazil.
The consortium, formed by O GLOBO, Extra, G1, Folha de S.Paulo, UOL and O Estado de S. Paulo, collects information from the state health departments, the above data was collected in the bulletin issued at 8:00 p.m.
Infographic: coronavirus figures in Brazil and around the world
The moving average of deaths, in turn, is 544.
The “7-day moving average” averages between the number of deaths for the day and the previous six. It is compared with an average of two weeks ago to indicate if there is an uptrend, stability or a downtrend. The calculation is a statistical resource to be able to see the trend of the data, drowning out the “noise” caused on weekends, when the notification of deaths due to a shortage of shift employees is reduced.
read more: See here how the coronavirus situation is in your state
In addition to the Federal District, the moving average of cases increased in 16 states. They are: Acre, Amapá, Ceará, Espírito Santo, Mato Grosso do Sul, Minas Gerais, Paraiba, Paraná, Pernambuco, Rio de Janeiro, Rio Grande do Norte, Rio Grande do Sul, Rondônia, Santa Catarina, São Paulo and Tocantins. There was only one descent in Piauí and Roraima.
The moving average of deaths increased in 11 states: Amapá, Ceará, Espírito Santo, Goiás, Minas Gerais, Paraná, Rio de Janeiro, Rio Grande do Sul, Santa Catarina, São Paulo and Tocantins. Deaths occurred in seven states: Acre, Alagoas, Mato Grosso, Mato Grosso do Sul, Piauí, Roraima and Sergipe.
First vaccine requests registration in the US.
The alliance between the American pharmaceutical group Pfizer and the German company BioNTech announced that on Friday it submitted an emergency authorization request for the commercialization of its vaccine against Covid-19. The request was made to the Food and Drug Administration (FDA), a US agency equivalent to Anvisa in Brazil, becoming the first manufacturer to take this step in the United States.
Second wave of Covid-19? Experts answer ten questions
– It is with great pride and joy, and even a little relief, that I can announce that our application for authorization for the emergency use of our Covid-19 vaccine is now in the hands of the FDA – said Albert Bourla, CEO from Pfizer, in a sentence.
Covid-19 reinfection unlikely
People who have had Covid-19 are unlikely to contract the new coronavirus for at least six months after their first infection, according to a British study of healthcare professionals at the forefront of the fight against the new coronavirus pandemic.
Read More: Rio de Janeiro and São Paulo achieve a new record of deaths from Covid-19 in the country
“This is very good news, as we can be sure that, at least in the short term, most people who have had Covid-19 will not have it again,” said David Eyre, a professor in the department of health of the population of Nuffield at the University of Oxford. one of the study leaders.
In the world, more than 50 million people worldwide have already been infected, the Oxford researchers noted. Isolated cases of reinfection had raised concerns that immunity might be short-lived and that recovered patients could quickly fall ill again.
